Long-term outcome of acute promyelocytic leukemia treated with all-trans-retinoic acid, arsenic trioxide, and gemtuzumab.
about
Recent advances in acute promyelocytic leukaemia.Gemtuzumab ozogamicin in acute myeloid leukemia.Characteristics and outcome of patients with therapy-related acute promyelocytic leukemia front-line treated with or without arsenic trioxide.Combination of arsenic trioxide and Dasatinib: a new strategy to treat Philadelphia chromosome-positive acute lymphoblastic leukaemia.TRIM proteins in blood cancers.
P2860
Long-term outcome of acute promyelocytic leukemia treated with all-trans-retinoic acid, arsenic trioxide, and gemtuzumab.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Long-term outcome of acute pro ...... enic trioxide, and gemtuzumab.
@en
type
label
Long-term outcome of acute pro ...... enic trioxide, and gemtuzumab.
@en
prefLabel
Long-term outcome of acute pro ...... enic trioxide, and gemtuzumab.
@en
P2093
P2860
P50
P1433
P1476
Long-term outcome of acute pro ...... enic trioxide, and gemtuzumab.
@en
P2093
Courtney DiNardo
David McCue
Deborah McCue
Elihu Estey
Keyur Patel
Maria Foudray
Mark Brandt
Naval Daver
Nitin Jain
Rajyalakshmi Luthra
P2860
P304
P356
10.1182/BLOOD-2016-09-736686
P407
P50
P577
2016-12-21T00:00:00Z